Pneumocystis jirovecii pneumonia in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009.

Barnbrock, Anke; Möricke, Anja; Barbaric, Draga; Jones, Neil; Koenig, Christa; Moser, Reinhard; Rohde, Marius; Salvador, Christina; Alten, Julia; Elitzur, Sarah; Groll, Andreas H; Lehrnbecher, Thomas (2024). Pneumocystis jirovecii pneumonia in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009. (In Press). British journal of haematology Wiley 10.1111/bjh.19382

Preview

Text Br_J_Haematol_-_2024_-_Barnbrock_-_Pneumocystis_jirovecii_pneumonia_in_paediatric_acute_lymphoblastic_leukaemia__A_report.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (314kB) | Preview

Pneumocystis jirovecii can cause life-threatening pneumonia (PjP), and patients with haematological malignancies are at high risk of this infection. Prophylactic measures have significantly decreased morbidity and mortality, but there is a paucity of contemporary data on the incidence and clinical course of PjP in well-defined and homogenous patient populations, such as children suffering from acute lymphoblastic leukaemia (ALL). In the multi-international trial AIEOP-BFM ALL2009, PjP was diagnosed in six children (incidence 1/1000) and was associated with insufficient prophylaxis in five of them. Although none of the patients died of PjP, the long-term impact of the infection is unclear.

Interest & Impact

Downloads

0 since deposited on 26 Mar 2024
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item